Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Newer Targets
Palleon Pharmaceuticals to Present Preclinical Data on EAGLE-Her2 and Anti-Siglec-9 Antibody…
Newer Targets
Codiak Presents First Preclinical Data for exoASO, Engineered Exosomes Designed to…
Newer Targets
Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Approval
AstraZeneca’s Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
Phase III
First China-manufactured Trastuzumab Biosimilar HLX02 Global Phase III Trial Met Primary…
Phase II
Abivax Receives French Regulatory Authority (ANSM) Approval to Include French Study…
Approval
BRUKINSA (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
AbbVie and Harpoon Expand Partnership with $510 Million Licensing Deal
Acquisitions
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
Deals
Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics
Lay off/Spin-off/Appointments
Eli Lilly to Add 100 Employees Following $400 Million Manufacturing Investment
Home
Commercial
Lay off/Spin-off/Appointments
Lay off/Spin-off/Appointments
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lay off/Spin-off/Appointments
Eli Lilly to Add 100 Employees Following $400 Million Manufacturing Investment
Biospace News
-
November 21, 2019
Lay off/Spin-off/Appointments
Sanofi in Talks to Sell, Spin-Off or Create Joint Venture of its Consumer Health Unit
Lay off/Spin-off/Appointments
CODA Biotherapeutics Deepens Gene Therapy Expertise with Industry Veteran, Annahita Keravala, Ph.D., and Key Promotions
Lay off/Spin-off/Appointments
Amgen to Cut Another 172 Jobs Following Layoff Announcement Earlier This Month
Lay off/Spin-off/Appointments
Novartis Cuts 150 Jobs As it Shifts Focus of Shanghai Facility to Drug Development
Lay off/Spin-off/Appointments
Eagle Pharmaceuticals Announces Departure of Douglas L. Braunstein from Board of...
Biospace News
-
November 14, 2019
0
Lay off/Spin-off/Appointments
Amgen Exits Neuroscience R&D, Plans to Cut 149 Jobs in Boston...
Biospace News
-
November 13, 2019
0
Lay off/Spin-off/Appointments
Employees Roll Up Their Sleeves and Give Back for Bayer’s Third...
Biospace News
-
October 16, 2019
0
Lay off/Spin-off/Appointments
Checkmate Pharmaceuticals Announces Additions to Management Team
Biospace News
-
October 15, 2019
0
Lay off/Spin-off/Appointments
Eli Lilly to Close UK Research Center, Affecting 270 Staffers
Biospace News
-
October 15, 2019
0
1
2
3
...
30
Page 1 of 30
- Advertisement -
MOST POPULAR
Alnylam Initiates ILLUMINATE-B Phase 3 Pediatric Study of Lumasiran for the...
April 15, 2019
Peroxfarma Spreads News About National Nutrition Month in March
March 28, 2019
FDA-approved drug effectively treats rare chronic immune disorder
April 3, 2019
Andexxa Highlighted as a First-Line Factor Xa Reversal Option by the...
November 15, 2019
Load more
HOT NEWS
Commercial
BioLineRx to Present at the 29th Annual Oppenheimer Healthcare Conference
Phase III
DARZALEX (daratumumab) Phase 3 MAIA Study Results, Published in The New...
Ophthalmology
On World Sight Day, Allergan Launches National Campaign to Raise Awareness...
Others
Rare Disease Fund to Provide Financial Support to Singaporeans with Rare...
